IntriCon Corporation (IIN) Analysts See $0.08 EPS

February 14, 2018 - By Darrin Black

 IntriCon Corporation (IIN) Analysts See $0.08 EPS
Investors sentiment decreased to 1.09 in 2017 Q3. Its down 0.51, from 1.6 in 2017Q2. It dived, as 1 investors sold IntriCon Corporation shares while 10 reduced holdings. 7 funds opened positions while 5 raised stakes. 2.30 million shares or 7.81% more from 2.13 million shares in 2017Q2 were reported.
Heartland Advisors Incorporated accumulated 0.6% or 772,559 shares. Moreover, California Employees Retirement Sys has 0% invested in IntriCon Corporation (NASDAQ:IIN) for 34,116 shares. Thompson Davis Communications Incorporated accumulated 0.05% or 2,500 shares. Morgan Stanley holds 7,279 shares or 0% of its portfolio. Jpmorgan Chase, a New York-based fund reported 700 shares. Bard Assocs accumulated 37,500 shares or 0.21% of the stock. Pacific Alternative Asset Ltd Limited Liability Company has 0.37% invested in IntriCon Corporation (NASDAQ:IIN). Renaissance Technology Limited holds 237,600 shares. Bridgeway Management has 0% invested in IntriCon Corporation (NASDAQ:IIN). Northern invested 0% of its portfolio in IntriCon Corporation (NASDAQ:IIN). Wells Fargo Mn owns 0% invested in IntriCon Corporation (NASDAQ:IIN) for 1 shares. Eam Ltd Liability Corp reported 48,620 shares. Blackrock invested in 0% or 36,093 shares. Gamco Investors Inc Et Al has invested 0% in IntriCon Corporation (NASDAQ:IIN). Us Savings Bank De reported 9,000 shares.

Analysts expect IntriCon Corporation (NASDAQ:IIN) to report $0.08 EPS on February, 15.They anticipate $0.20 EPS change or 166.67 % from last quarter’s $-0.12 EPS. IIN’s profit would be $549,521 giving it 61.72 P/E if the $0.08 EPS is correct. After having $0.15 EPS previously, IntriCon Corporation’s analysts see -46.67 % EPS growth. The stock increased 8.82% or $1.6 during the last trading session, reaching $19.75. About 189,403 shares traded or 148.10% up from the average. IntriCon Corporation (NASDAQ:IIN) has risen 44.30% since February 14, 2017 and is uptrending. It has outperformed by 27.60% the S&P500.

IntriCon Corporation (NASDAQ:IIN) Ratings Coverage

Among 3 analysts covering IntriCon (NASDAQ:IIN), 1 have Buy rating, 1 Sell and 1 Hold. Therefore 33% are positive. IntriCon had 3 analyst reports since September 22, 2015 according to SRatingsIntel. The rating was maintained by Dougherty & Company with “Buy” on Friday, February 17. Zacks downgraded IntriCon Corporation (NASDAQ:IIN) on Tuesday, September 22 to “Sell” rating. The stock of IntriCon Corporation (NASDAQ:IIN) earned “Neutral” rating by Longbow on Friday, August 25.

IntriCon Corporation, together with its subsidiaries, designs, develops, engineers, makes, and distributes body-worn devices in the United States, Europe, Asia, and internationally. The company has market cap of $135.66 million. The firm operates in two divisions, Body Worn Devices and Hearing Health Direct-To-Consumer. It currently has negative earnings. It offers micro-miniature products, microelectronics, micro-mechanical assemblies, high-precision injection-molded plastic components, and assemblies and software solutions for bio-telemetry devices, hearing instruments, and professional audio communication devices.

More notable recent IntriCon Corporation (NASDAQ:IIN) news were published by: which released: “IntriCon Corp.” on June 22, 2017, also with their article: “Investors buy into disruption story at IntriCon Corp.” published on November 12, 2017, published: “IntriCon Corporation’s (IIN) CEO Mark Gorder on Q2 2017 Results – Earnings …” on August 02, 2017. More interesting news about IntriCon Corporation (NASDAQ:IIN) were released by: and their article: “IntriCon Reports 2017 Fourth-Quarter and Full-Year Results” published on February 12, 2018 as well as‘s news article titled: “IntriCon Exercises Option to Acquire Remaining Stake in Hearing Help Express” with publication date: January 19, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter: